CD8A and sarcoma: Here we used mass cytometry analysis in combination with a multiplex combinatorial tetramer staining approach23 to screen for CD8+ T cells targeting a broad range of antigen candidates across tissues from mice bearing progressively growing MCA-induced sarcomas that are susceptible to checkpoint blockade immunotherapy.